Literature DB >> 11948776

Postoperative management of subthalamic nucleus stimulation for Parkinson's disease.

Paul Krack1, Valérie Fraix, Alexandre Mendes, Alim-Louis Benabid, Pierre Pollak.   

Abstract

The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson' s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel decrease in antiparkinsonian medication while assessing the interactions of both treatments. Neurologists responsible for postoperative management of patients receiving STN DBS must have expert knowledge of the electroanatomy of the subthalamic area and be familiar with the medical treatment of motor and nonmotor symptoms, including the management of long-term complications of levodopa treatment. Neurosurgeons who perform DBS need to understand the principles that guide the postoperative adaptation of treatment. This article defines guidelines for setting stimulation parameters, adapting drugs and managing adverse effects. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948776     DOI: 10.1002/mds.10163

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  51 in total

Review 1.  High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.

Authors:  R Carron; V Fraix; C Maineri; E Seigneuret; B Piallat; P Krack; P Pollak; A L Benabid; Stéphan Chabardès
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

2.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

3.  Motor and non motor effects during intraoperative subthalamic stimulation for Parkinson's disease.

Authors:  Paul Sauleau; Sylvie Raoul; François Lallement; Isabelle Rivier; Sophie Drapier; Youenn Lajat; Marc Verin
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

4.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

5.  Neural origin of evoked potentials during thalamic deep brain stimulation.

Authors:  Alexander R Kent; Warren M Grill
Journal:  J Neurophysiol       Date:  2013-05-29       Impact factor: 2.714

6.  Latency of subthalamic nucleus deep brain stimulation-evoked cortical activity as a potential biomarker for postoperative motor side effects.

Authors:  Zachary T Irwin; Mohammad Z Awad; Christopher L Gonzalez; Arie Nakhmani; J Nicole Bentley; Thomas A Moore; Kenneth G Smithson; Barton L Guthrie; Harrison C Walker
Journal:  Clin Neurophysiol       Date:  2020-03-12       Impact factor: 3.708

7.  Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Authors:  Nader Pouratian; Sandeep Thakkar; Won Kim; Jeff M Bronstein
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-09-04

8.  Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus.

Authors:  L Castelli; P Perozzo; M L Genesia; E Torre; M Pesare; A Cinquepalmi; M Lanotte; B Bergamasco; L Lopiano
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

Review 9.  Practical considerations and nuances in anesthesia for patients undergoing deep brain stimulation implantation surgery.

Authors:  Danielle Teresa Scharpf; Mayur Sharma; Milind Deogaonkar; Ali Rezai; Sergio D Bergese
Journal:  Korean J Anesthesiol       Date:  2015-07-28

10.  Shorter pulse generator longevity and more frequent stimulator adjustments with pallidal DBS for dystonia versus other movement disorders.

Authors:  Pawan V Rawal; Leonardo Almeida; Luke B Smelser; He Huang; Barton L Guthrie; Harrison C Walker
Journal:  Brain Stimul       Date:  2014-01-18       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.